Gene · 9134
Papers2,792
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 2,792
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| DIXDC1 Promotes Lymphatic Metastasis and Resistance to Cuproptosis in Bladder Cancer Through Mediating DLAT. | Adv Sci (Weinh) | 2026 | 42658569 | PubTator, text mining | PubMed |
| Feed restriction affects follicular development by regulating cell cycle progression in porcine mural granulosa cells. | J Anim Sci Biotechnol | 2026 | 42482127 | PubTator, text mining | PubMed |
| Self-organizing three-dimensional dermal papilla cell spheroids yield therapeutic extracellular vesicles that target hypertrophic scar regression via the miR-26a-5p/CCNE2 axis. | Burns Trauma | 2026 | 42421776 | PubTator, text mining | PubMed |
| Orientin inhibits cyclin E/cyclin A-CDK2 to induce growth arrest at senescence in human gastric cancer cells. | Food Chem Toxicol | 2026 | 42303079 | PubTator, text mining | PubMed |
| [MUTYH-APEX1 Axis Promotes Hepatocellular Carcinoma Progression and Therapeutic Resistance by Regulating Cell Cycle Proteins]. | Sichuan Da Xue Xue Bao Yi Xue Ban | 2026 | 42021884 | PubTator, text mining | PubMed |
| RNA N6-methyladenosine (m6A) regulates cell cycle progression in diffuse midline glioma (DMG) and confers sensitivity to FTO inhibition. | Cell Death Dis | 2026 | 41888518 | PubTator, text mining | PubMed |
| Precision Design in Cancer Treatment: Cucurbitacin E Modulates AMPK, PGK1, and PKM2 to Optimize Radiation Efficacy in Melanoma. | Curr Pharm Des | 2026 | 41832669 | PubTator, text mining | PubMed |
| Hsa-microRNA-34a-5p inhibits virus-negative Merkel cell carcinoma cell proliferation and migration by regulating cell cycle- and EMT-related pathways and suppresses tumor spheroid formation. | J Dermatol Sci | 2026 | 41820098 | PubTator, text mining | PubMed |
| Understanding the Mechanisms of Human Liver Regeneration via Characterization of Circulating Extracellular Vesicles. | Biomed Res Int | 2026 | 41810218 | PubTator, text mining | PubMed |
| PVT1 lincRNA signals an androgen-dependent transcriptional activation program of oncogenes in prostate cancer cells. | Int J Cancer | 2026 | 41792045 | PubTator, text mining | PubMed |
| Pharmacological inhibition of frizzled 4 delays cell cycle progression and limits oral squamous cell carcinoma growth. | Front Cell Dev Biol | 2026 | 41783595 | PubTator, text mining | PubMed |
| HES1 oscillations are required for cell cycle reentry in oestrogen receptor-positive breast cancer cells. | Proc Natl Acad Sci U S A | 2026 | 41770916 | PubTator, text mining | PubMed |
| The Src inhibitor peptide TAT-Cx43266-283 improves survival in an intracranial murine model of lung cancer brain metastasis. | Neurooncol Adv | 2026 | 41756757 | PubTator, text mining | PubMed |
| Paired-Box (PAX) Gene Signatures as a Biomarker of Breast Cancer Progression. | Int J Mol Sci | 2026 | 41752124 | PubTator, text mining | PubMed |
| A Review of Ionizing Radiation-Induced Senescence of Bone Marrow Mesenchymal Stem/Stromal Cells: Mechanisms and Therapeutic Strategies. | Curr Issues Mol Biol | 2026 | 41751458 | PubTator, text mining | PubMed |
| Lactate metabolism and protein lactylation in cancer. | Mol Biomed | 2026 | 41746580 | PubTator, text mining | PubMed |
| Mathematical analysis of G1/S sub-networks in hematopoietic proliferation: Sequential and lineage-specific activation. | iScience | 2026 | 41717016 | PubTator, text mining | PubMed |
| 8-Oxoguanine modifications in seed regions of miRNAs regulating P16 promote aging by reshaping gene regulatory networks. | Free Radic Biol Med | 2026 | 41690606 | PubTator, text mining | PubMed |
| OSMR coordinates a self-perpetuating circuit linking chemoresistance and neutrophil-driven immunosuppression in gastric cancer. | Neoplasia | 2026 | 41653653 | PubTator, text mining | PubMed |
| Separate transcription and splicing gene networks are linked and coordinated by the pRb-E2F pathway. | Nucleic Acids Res | 2026 | 41614303 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9134/papers